NCT05755243View on ClinicalTrials.gov

Human Subcutaneous Inflammatory Response to Glucose Sensors

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

June 21, 2022

Primary Completion Date

July 12, 2023

Study Completion Date

September 20, 2023

Conditions
Inflammatory Response to Glucose Sensors
Interventions
DEVICE

glucose sensor

skin biopsy (punch)

Trial Locations (1)

08208

Hospital Parc Tauli, Sabadell

Sponsors
All Listed Sponsors
lead

Corporacion Parc Tauli

OTHER

NCT05755243 - Human Subcutaneous Inflammatory Response to Glucose Sensors | Biotech Hunter | Biotech Hunter